CA2719437A1 - Method and composition for the regeneration of tissue with the aid of stem cells or bone-marrow cells - Google Patents

Method and composition for the regeneration of tissue with the aid of stem cells or bone-marrow cells Download PDF

Info

Publication number
CA2719437A1
CA2719437A1 CA2719437A CA2719437A CA2719437A1 CA 2719437 A1 CA2719437 A1 CA 2719437A1 CA 2719437 A CA2719437 A CA 2719437A CA 2719437 A CA2719437 A CA 2719437A CA 2719437 A1 CA2719437 A1 CA 2719437A1
Authority
CA
Canada
Prior art keywords
cells
blood
tissue
bone
stem cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2719437A
Other languages
English (en)
French (fr)
Inventor
Augustinus Bader
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2719437A1 publication Critical patent/CA2719437A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2719437A 2008-03-31 2009-03-24 Method and composition for the regeneration of tissue with the aid of stem cells or bone-marrow cells Abandoned CA2719437A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08006238 2008-03-31
EP08006238.3 2008-03-31
PCT/EP2009/002135 WO2009121503A2 (de) 2008-03-31 2009-03-24 Verfahren und zusammensetzung zur regeneration von gewebe mit hilfe von stamm- oder knochenmarkzellen

Publications (1)

Publication Number Publication Date
CA2719437A1 true CA2719437A1 (en) 2009-10-08

Family

ID=41103846

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2719437A Abandoned CA2719437A1 (en) 2008-03-31 2009-03-24 Method and composition for the regeneration of tissue with the aid of stem cells or bone-marrow cells

Country Status (8)

Country Link
US (1) US20110020299A1 (https=)
EP (1) EP2273997B1 (https=)
JP (1) JP2011516436A (https=)
CN (1) CN101980714A (https=)
AU (1) AU2009231139A1 (https=)
CA (1) CA2719437A1 (https=)
RU (1) RU2491076C2 (https=)
WO (1) WO2009121503A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110280838A1 (en) * 2007-12-27 2011-11-17 Advanced Technologies And Regenerative Medicine, Llc Treatment of intervertebral disc degeneration using human umbilical cord tissue-derived cells
WO2011153512A2 (en) * 2010-06-03 2011-12-08 Indiana University Research And Technology Corporation Use of compounds with thrombopoietic activity to promote bone growth and healing
US20150065425A1 (en) * 2013-09-02 2015-03-05 Muffin Incorporated Products comprising an extracellular matrix material and osteogenic protein
CN104524636B (zh) * 2014-12-19 2017-06-16 中国人民解放军第四军医大学 通过定向诱导骨髓间充质干细胞获得组织工程软骨的方法
RU2614665C1 (ru) * 2015-12-18 2017-03-28 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Способ стимуляции репаративного ангиогенеза и регенерации соединительной ткани, при её повреждении, методом генной терапии с использованием видоспецифичных генов белковых факторов vegf и fgf2, в ветеринарии, и генетическая конструкция для реализации заявленного способа
CN106581772B (zh) * 2016-12-02 2020-02-18 四川大学华西医院 携带G-CSF缓释系统的Fibrin-HA水凝胶及其制备方法和用途
KR101772449B1 (ko) 2016-12-27 2017-08-30 주식회사 하이센스바이오 신규한 펩타이드
RU2687007C2 (ru) * 2017-09-12 2019-05-06 Общество с ограниченной ответственностью "Клеточные Системы" Способ биотехнологического восстановления кожного покрова аллогенными стволовыми клетками человека
JP7110360B2 (ja) 2017-10-09 2022-08-01 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー 凍結乾燥方法
KR101943978B1 (ko) 2017-12-28 2019-01-30 주식회사 하이센스바이오 신규한 펩타이드
RU2669726C1 (ru) * 2018-01-10 2018-10-15 Диана Малхазовна Обидняк Способ повышения эффективности вспомогательных репродуктивных технологий у пациенток с повторными неэффективными попытками имплантации
CN113597532B (zh) 2019-03-14 2023-02-17 泰尔茂比司特生物技术有限公司 冻干容器填充固定装置、系统及使用方法
RU2747589C1 (ru) * 2019-12-09 2021-05-11 Руслан Яверович Атлуханов Способ лечения повреждения мениска коленного сустава
CN116712597B (zh) * 2023-06-12 2026-04-17 广州正源生物技术有限公司 一种复合生物敷料及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE439849T1 (de) * 1996-04-19 2009-09-15 Osiris Therapeutics Inc Die wiederherstellung und verstärkung von knochen mittels mesenchymalen stammzellen
WO2000018885A1 (en) * 1998-09-29 2000-04-06 Gamida Cell Ltd. Methods of controlling proliferation and differentiation of stem and progenitor cells
AU2003253015A1 (en) * 2002-06-20 2004-01-06 Bionethos Holding Gmbh Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure
US20040191215A1 (en) * 2003-03-25 2004-09-30 Michael Froix Compositions for induction of a therapeutic response
ATE469654T1 (de) * 2003-12-30 2010-06-15 Augustinus Bader Verwendung des erythropoietins zur regeneration von lebergewebe
DE102004004509B4 (de) * 2004-01-23 2010-07-01 Epoplus Gmbh Co.Kg Einsatz von niedrig dosiertem Erythropoietin zur Stimulation endothelialer Vorläuferzellen sowie zur Organregeneration und Progressionsverlangsamung von Endorganschäden
ITRM20060289A1 (it) * 2006-05-31 2007-12-01 Ranieri Cancedda Bio membrana ingegnerizzata osteo angiogenica e suoi usi per la rigenerazione di tessuto osseo

Also Published As

Publication number Publication date
EP2273997B1 (de) 2016-01-13
JP2011516436A (ja) 2011-05-26
RU2010142988A (ru) 2012-05-10
EP2273997A2 (de) 2011-01-19
WO2009121503A3 (de) 2009-11-26
RU2491076C2 (ru) 2013-08-27
US20110020299A1 (en) 2011-01-27
WO2009121503A2 (de) 2009-10-08
AU2009231139A1 (en) 2009-10-08
CN101980714A (zh) 2011-02-23

Similar Documents

Publication Publication Date Title
US20110020299A1 (en) Method and composition for the regeneration of tissue with the aid of stem cells or bone marrow cells
US6703038B1 (en) Injectable bone substitute material containing non-ceramic hydroxyapatite cement
Tozum et al. Platelet-rich plasma: a promising innovation in dentistry
Everts et al. Platelet-rich plasma and platelet gel: a review
JP6640808B2 (ja) 異なる密度の成分を有する粒子状組織グラフトならびにそれを作成および使用する方法
US20210030805A1 (en) Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo
Anitua et al. Perspectives and challenges in regenerative medicine using plasma rich in growth factors
EP1143983B1 (en) Spray delivery of cells
CN112220802A (zh) 伤口修复剂组合物的制备工艺、管子及装置
AU2010210141A1 (en) Method and means for producing tissues and tissues obtained
Kerche-Silva Natural Rubber Latex Biomaterials in Bone
AU2002239965B2 (en) Stimulation of bone growth and cartilage formation with thrombing peptide derivatives
CA2480554A1 (en) Bone generation by gene therapy
AU2002239965A1 (en) Stimulation of bone growth and cartilage formation with thrombing peptide derivatives
JP2014230685A (ja) 歯周組織形成用材料
JP2004531453A (ja) トランスフェクション系
JP2006122518A (ja) 骨又は歯周組織形成用組成物
Dai et al. Tissue engineering scaffold slowly releasing neurotrophic factors to bridge long peripheral nerve defect
De et al. Orthopaedic Surgery: Basic Science and Clinical Applications
CN112717204A (zh) 自体骨移植物活性替代物组合物、制备方法及应用
Nofal et al. Application of the Biological Substitutes and Tissue Engineering in Maxillofacial Regeneration

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20140325